-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Xeris Biopharma Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2024.
- Xeris Biopharma Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 149M shares, a 7.92% increase year-over-year.
- Xeris Biopharma Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 138M shares, a 1.51% increase from 2022.
- Xeris Biopharma Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 136M shares, a 71.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)